← Back to Search

Screening Interventions for Colorectal Cancer (SMARTER CRC Trial)

N/A

Recruiting

Led By Gloria Coronado, PhD

Research Sponsored by OHSU Knight Cancer Institute

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 36 months

Awards & highlights

SMARTER CRC Trial Summary

This trial is looking at how to best reduce colorectal cancer rates in the US by partnering clinics with health plans. They hope to improve screening and follow-up rates in rural Medicaid patients.

Who is the study for?

This trial is for Medicaid patients aged 45-75 in rural areas who need colorectal cancer screening. Clinics and staff willing to participate, collect data, and implement the intervention are eligible. Excluded are those current on screenings or with conditions making them poor candidates.Check my eligibility

What is being tested?

The study tests a model using interviews, fecal immunochemical testing, and patient navigation to increase colorectal cancer screening rates in rural settings through clinic-health plan partnerships.See study design

What are the potential side effects?

Since this trial involves non-invasive procedures like interviews and fecal tests rather than medication or surgery, side effects are minimal but may include discomfort or anxiety from discussing personal health issues.

SMARTER CRC Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 36 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 36 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 36 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Colorectal Carcinoma

Secondary outcome measures

Adaptations to core program components made by payer or clinic

Adenomas or cancers detected

Colonoscopy referral

+9 more

SMARTER CRC Trial Design

2Treatment groups

Active Control

Group I: SMARTER CRC Intervention Year 1Active Control3 Interventions

In year 1, patients receive mailed FITs from CCO, screening reminders from clinics, and patient navigation as appropriate; Health record data collected.

Group II: SMARTER CRC Intervention Year 2Active Control3 Interventions

In year 2, patients receive mailed FITs from CCO, screening reminders from clinics, and patient navigation as appropriate; Health record data collected.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

National Cancer Institute (NCI)NIH

13,660 Previous Clinical Trials

40,906,646 Total Patients Enrolled

Oregon Health and Science UniversityOTHER

973 Previous Clinical Trials

7,368,124 Total Patients Enrolled

OHSU Knight Cancer InstituteLead Sponsor

230 Previous Clinical Trials

2,073,038 Total Patients Enrolled

Media Library

Fecal Immunochemical Test Clinical Trial Eligibility Overview. Trial Name: NCT04890054 — N/A

Colorectal Cancer Research Study Groups: SMARTER CRC Intervention Year 1, SMARTER CRC Intervention Year 2

Colorectal Cancer Clinical Trial 2023: Fecal Immunochemical Test Highlights & Side Effects. Trial Name: NCT04890054 — N/A

Fecal Immunochemical Test 2023 Treatment Timeline for Medical Study. Trial Name: NCT04890054 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What objectives has this experiment been designed to fulfill?

"The purpose of this research is to measure the probability of colorectal cancer screening for eligible patients 6 months after patient list pull date. Secondary goals include determining the timeframes from mailing a fecal immunochemical test (FIT) or other tests, such as colonoscopies or flexible sigmoidoscopy, and completion of those procedures; additionally, researchers are measuring if any form of patient navigation has been implemented in the intervention group."

Answered by AI

What is the current enrollment count for this research project?

"Affirmative. According to the clinicaltrials.gov website, this medical trial is currently open for recruitment and was initially posted on May 14th 2021. The last edit occurred on September 6th 2022 and 17688 patients are needed from a single site."

Answered by AI

Are there vacancies for individuals seeking to join this experiment?

"Affirmative. Details available on clinicaltrials.gov establish that recruitment for this medical experiment is still ongoing, with the original posting date being May 14th 2021 and most recent edit made to it in September 6th 2022. The trial seeks to enrol 17688 participants from 1 site."

Answered by AI

Recent research and studies

Implementation Science CommunicationsJournal

Mailed Fecal Testing and Patient Navigation Versus Usual Care to Improve Rates of Colorectal Cancer Screening and Follow-up Colonoscopy in Rural Medicaid Enrollees: A Cluster-randomized Controlled Trial

Coronado, Gloria D., Michael C. Leo, Katrina Ramsey, Jennifer Coury, Amanda F. Petrik, Mary Patzel, Erin S. Kenzie, et al.. 2022. “Mailed Fecal Testing and Patient Navigation Versus Usual Care to Improve Rates of Colorectal Cancer Screening and Follow-up Colonoscopy in Rural Medicaid Enrollees: A Cluster-randomized Controlled Trial”. Implementation Science Communications. Springer Science and Business Media LLC. doi:10.1186/s43058-022-00285-3.

clinicaltrials.govStudy

Screening More Patients for Colorectal Cancer Through Adapting and Refining Targeted Evidence-Based Interventions in Rural Settings, SMARTER CRC

Melinda Davis 2021. "Screening More Patients for Colorectal Cancer Through Adapting and Refining Targeted Evidence-Based Interventions in Rural Settings, SMARTER CRC". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04890054.